Experience

Securing $240 million and a jury verdict of willful infringement for Promptu in patent case against Comcast

Promptu Systems Corporation

US Synthetic secures ITC exclusion order barring polycrystalline diamond compacts (PDCs)

US Synthetic Corporation

Achieving precedent in preserving valuable patents for Lumify®

Eye Therapies, LLC

Finnegan client Maglula delivers crushing blow to Amazon’s arbitration practices over counterfeit products

Maglula, Ltd.

Finnegan secures $180M for CSRC in complex arbitrations

CSRC et al.

Protecting a blockbuster diabetes treatment for AstraZeneca

AstraZeneca AB

Major victories across IP venues for Volkswagen, Audi, Bentley, and Lamborghini

Audi AG; Audi of America, LLC; Automobili Lamborghini America, LLC; Automobili Lamborghini S.p.A.; Bentley Motors Limited; Bentley Motors, Inc; Volkswagen AG; Volkswagen Group of America, Inc.

Finnegan tees up valuable patents for Eisai, leading to major strategic collaboration agreement

Eisai Co., Ltd.

Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million

Intellia Therapeutics, Inc.

Recent Experience

Experience

Bayer Cropscience LP et al. v. Corteva Agriscience LLC et al. Bayer Cropscience LP et al. v. Corteva Agriscience LLC et al.

N22C-07-168, Delaware Superior Court, Complex Commercial Litigation Division

Experience

Ningde Amperex Technology Limited v. Zhuhai CosMX Battery Co., Ltd. Ningde Amperex Technology Limited v. Zhuhai CosMX Battery Co., Ltd.

2:22-cv-00232, E.D. Tex., Judge Gilstrap

Experience

Representative Engagement: Finnegan secures $180M for CSRC in complex arbitrations - GENZYME CORP. v. CSRC et al., Case No. 01-19-0001-6937, 01-20-0000-5081

Finnegan secures $180M for CSRC in complex arbitrations Finnegan secures $180M for CSRC in complex arbitrations

01-19-0001-6937; 01-20-0000-5081, AAA

Experience

Arbitration victory for major U.S. pharmaceutical company Arbitration victory for major U.S. pharmaceutical company

Experience

BCL-2 inhibitors licensing agreement for Fochon Pharmaceuticals, Ltd. BCL-2 inhibitors licensing agreement for Fochon Pharmaceuticals, Ltd.

Fochon Pharmaceuticals, Ltd.

Experience

Finnegan successfully represents U.S. pharmaceutical company in an arbitration Finnegan successfully represents U.S. pharmaceutical company in an arbitration

Experience

Global cross-licensing for specialty chemicals company Global cross-licensing for specialty chemicals company

Experience

Lipid nanoparticle licensing and collaboration agreements for Genevant Sciences Lipid nanoparticle licensing and collaboration agreements for Genevant Sciences

Genevant Sciences

Experience

Multiple settlement and license agreements for AbbVie, Inc. Multiple settlement and license agreements for AbbVie, Inc.

AbbVie, Inc.

Experience

Small molecule product development agreement for Roivant Sciences Small molecule product development agreement for Roivant Sciences

Roivant Scientists

Experience

Dorco Company, Ltd. v. The Gillette Company, LLC Dorco Company, Ltd. v. The Gillette Company, LLC

1:18-cv-01306, D. Del., Judge Stark

Experience

BLU Products, Inc. v. LG Electronics, Inc., et al. BLU Products, Inc. v. LG Electronics, Inc., et al.

2:17-cv-00458, E.D. Tex., Judge Gilstrap

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.